We are live on ! Find out more
NSPR icon

InspireMD
NSPR

36 hedge funds and large institutions have $31.9M invested in InspireMD in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

3% more funds holding

Funds holding: 35 → 36 (+1)

2.39% more ownership

Funds ownership: 43.51% → 45.9% (+2.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less capital invested

Capital invested by funds: $34.7M → $31.9M (-$2.83M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $8K

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
9
Increased
8
Reduced
–
Closed
8
Calls
–
Puts
$8K
Net Calls
-$8K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
SCM
Soleus Capital Management
Connecticut
+$2.34M
2
UBS Group
UBS Group
Switzerland
+$311K
3
PHP
Parkman Healthcare Partners
Connecticut
+$159K
4
IIM
Ironwood Investment Management
Massachusetts
+$151K
5
BlackRock
BlackRock
New York
+$91.1K

Top Sellers

Rank Fund Capital Flow
1
EIM
Essex Investment Management
Massachusetts
-$195K
2
Renaissance Technologies
Renaissance Technologies
New York
-$84.4K
3
DIA
Dana Investment Advisors
Wisconsin
-$80.9K
4
NA
Nottingham Advisors
New York
-$80.7K
5
LCM
Legato Capital Management
California
-$47.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$5.26M – – –
RA
2
Rosalind Advisors
Ontario, Canada
$5.2M +$35.2K +14,109 +0.6%
O
3
OrbiMed
New York
$4.84M – – –
SCM
4
Soleus Capital Management
Connecticut
$4.28M +$2.34M +940,831 +100%
Marshall Wace
5
Marshall Wace
United Kingdom
$4.22M – – –
PHP
6
Parkman Healthcare Partners
Connecticut
$2.8M +$159K +63,889 +5%
VCIM
7
Velan Capital Investment Management
Georgia
$2.05M – – –
PVI
8
Pura Vida Investments
New York
$1.02M – – –
AF
9
Affiance Financial
Minnesota
$429K – – –
UBS Group
10
UBS Group
Switzerland
$283K +$311K +124,638 New
HA
11
Huntleigh Advisors
Missouri
$282K +$17K +6,821 +6%
Morgan Stanley
12
Morgan Stanley
New York
$214K +$57K +22,875 +32%
IIM
13
Ironwood Investment Management
Massachusetts
$137K +$151K +60,547 New
Northern Trust
14
Northern Trust
Illinois
$103K +$1.07K +431 +1%
Raymond James Financial
15
Raymond James Financial
Florida
$101K +$24.9K +10,000 +29%
SSA
16
Schonfeld Strategic Advisors
New York
$85.1K +$8.36K +3,356 +10%
BlackRock
17
BlackRock
New York
$83K +$91.1K +36,573 New
CC
18
Courier Capital
New York
$68.1K – – –
MFIM
19
Mesirow Financial Investment Management
Illinois
$68.1K – – –
Citadel Advisors
20
Citadel Advisors
Florida
$59.4K +$65.2K +26,176 New
HCM
21
Hollencrest Capital Management
California
$45.4K – – –
Creative Planning
22
Creative Planning
Kansas
$44.4K +$48.7K +19,555 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$41.4K – – –
VPWA
24
Vestia Personal Wealth Advisors
Indiana
$40.9K +$44.8K +18,000 New
Millennium Management
25
Millennium Management
New York
$38.6K – – –
1
2

NSPR Hedge Fund Activity: Q2 2025 in Review

36 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2025, worth a combined $31.9M — down 8.1% from $34.7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NSPR positions and 8 closed out — a net gain of 1 holder — while 8 added to existing stakes and 0 trimmed.

The largest buyer was Soleus Capital Management, adding an estimated $2.34M. The largest seller was Essex Investment Management, exiting entirely with an estimated $195K sold.

  • 36 institutional investors held InspireMD (NSPR) as of Q2 2025, up from 35 in Q1 2025.
  • Funds reported $31.9M of InspireMD stock for Q2 2025, down 8.1% quarter-over-quarter.
  • 9 funds opened new InspireMD positions in Q2 2025 and 8 closed out, a net change of +1 holder.
  • The largest InspireMD buyer in Q2 2025 was Soleus Capital Management, an estimated $2.34M added.
  • The largest InspireMD seller in Q2 2025 was Essex Investment Management, an estimated $195K sold.

Based on aggregated 13F filings for Q2 2025.